GAMCO Investors, Inc.OTC: GAMI

Gabelli To Host 8th Annual Healthcare Symposium

Oct 26, 2026 at 8:00 AM EDT · Issued by GAMCO Investors, Inc. via GlobeNewswire

Summary by 6ix AI

Gabelli is hosting its 8th Annual Healthcare Symposium with Columbia Business School on Friday, November 13, 2026, at the Paley Center in New York. It will also be available by live webcast for those who cannot attend in person.

Key details

Topics are the pace of cancer-treatment (oncology) innovation, drug access in the specialty and GLP-1 era (GLP-1 refers to a class of diabetes and weight-loss drugs), and the role of artificial intelligence in care delivery.
Breakfast and networking begin at 8:00 AM, opening remarks run 8:45 to 8:50 AM, three panels run between 8:50 AM and 12:20 PM with short breaks between them, and closing remarks run until 12:30 PM.
Panelists include executives from Northwell Cancer Institute, Legend Biotech, Kite, a Gilead Company, AstraZeneca, McKesson, Gravie, Eli Lilly and Company, Cencora, Innovaccer, Optum, Teladoc Health and InnovAge, with panels moderated by Gabelli staff and a Columbia Business School professor.
Space is limited, and Gabelli asks those interested to register on its website as soon as possible.

What’s still pending

Participants are subject to change.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/gabelli-to-host-8th-annual-healthcare-symposium

PALM BEACH, Florida, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Gabelli is hosting the 8th Annual Healthcare Symposium in conjunction with Columbia Business School on Friday, November 13, 2026, at the Paley Center in New York. The symposium brings together leading companies and organizations from across the healthcare ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals.

This year’s program will cover the pace of oncology innovation, drug access in the specialty and GLP-1 era, and the role of artificial intelligence in care delivery.

For additional information and to register, please visit our website. Space is limited, so please register as soon as possible. For those who cannot attend in person, the symposium will also be available via live webcast.

Program:
Opening Remarks & Welcome Address (8:45 – 8:50 AM)

Cancer’s Breakthrough Year: Can Care Keep Pace? (8:50 – 9:50 AM)
Moderated by Rebecca Stern, PhD, SVP, Gabelli
Richard Barakat, MD, MBA (CBS ’14), Physician-in-Chief & Executive Director, Northwell Cancer Institute
Alan Bash, MBA (CBS ’99), President of CARVYKTI®, Legend Biotech (NASDAQ: LEGN)
Christophe Griolet, PharmD, MBA, VP & General Manager, US Commercial Organization, Kite, a Gilead Company (NASDAQ: GILD)
Mohit Manrao, MBA, SVP, Head of US Oncology, AstraZeneca (NYSE: AZN)

Drug Access in the Specialty and GLP-1 Era (10:05 – 11:05 AM)
Moderated by Daniel Barasa, MBA, Portfolio Manager, Gabelli
Natalie Bedford, SVP, US Pharmaceutical Distribution Services, McKesson (NYSE: MCK)
Marko Blagojevic, PharmD, SVP, Pharmacy, Gravie
Leonard Glass, MD, FACE, SVP, Cardiometabolic Health, Global Medical Affairs, Eli Lilly and Company (NYSE: LLY)
David Senior, MPH, President & SVP, Strategic Global Sourcing and Policy Economics, Cencora (NYSE: COR)

Leveraging AI to Improve Care Delivery (11:20 AM – 12:20 PM)
Moderated by Carri Chan, PhD, Cain Brothers and Company Professor of Healthcare Management and Faculty Director, Columbia Business School
Anil Jain, MD, Chief Innovation Officer, Provider Digital Transformation, Innovaccer
Kevin Larsen, MD, SVP, Clinical Innovation, Optum (NYSE: UNH)
Dave Ross, Chief Technology Officer, Teladoc Health (NYSE: TDOC)
Paul Taheri, MD, MBA, Chief Medical Officer, InnovAge (NASDAQ: INNV)

Closing Remarks (12:20 – 12:30 PM)
Breakfast and networking begin at 8:00 AM. Participants are subject to change.

Click here to register for the 8^th Annual Healthcare Symposium or scan the QR code.

Contact

Patricio Salem
P: 914-921-5117
E: [email protected]

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/226ab686-f6e1-4cef-8a44-50c82b754e9a